Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2024

Report ID: 1234416 | Published Date: Sep 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Adeno Carcinomas
        1.2.3 Mucinous Carcinomas
        1.2.4 Adenosquamous Carcinomas
    1.3 Market by Application
        1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Infectious Disease
        1.3.3 Cancer
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2016-2027)
    2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
        2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 mRNA Cancer Vaccines and Therapeutics Industry Dynamic
        2.3.1 mRNA Cancer Vaccines and Therapeutics Market Trends
        2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
        2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
        2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
        3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
    3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
        3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
    3.5 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
    3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
    3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
    4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2022-2027)

5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
    5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
    6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type
        6.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
    6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application
        6.3.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
    6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
        6.4.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
    7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
        7.2.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
    7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
        7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
    7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
        7.4.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type
        8.2.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application
        8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
        8.4.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
    9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type
        9.2.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application
        9.3.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country
        9.4.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
        10.2.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
        10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
        10.4.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Moderna Therapeutics
        11.1.1 Moderna Therapeutics Company Details
        11.1.2 Moderna Therapeutics Business Overview
        11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
        11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.1.5 Moderna Therapeutics Recent Development
    11.2 CureVac
        11.2.1 CureVac Company Details
        11.2.2 CureVac Business Overview
        11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
        11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.2.5 CureVac Recent Development
    11.3 Translate Bio
        11.3.1 Translate Bio Company Details
        11.3.2 Translate Bio Business Overview
        11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
        11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.3.5 Translate Bio Recent Development
    11.4 BioNTech
        11.4.1 BioNTech Company Details
        11.4.2 BioNTech Business Overview
        11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
        11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.4.5 BioNTech Recent Development
    11.5 Sangamo Therapeutics
        11.5.1 Sangamo Therapeutics Company Details
        11.5.2 Sangamo Therapeutics Business Overview
        11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
        11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.5.5 Sangamo Therapeutics Recent Development
    11.6 Argos Therapeutics
        11.6.1 Argos Therapeutics Company Details
        11.6.2 Argos Therapeutics Business Overview
        11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
        11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.6.5 Argos Therapeutics Recent Development
    11.7 In-Cell-Art
        11.7.1 In-Cell-Art Company Details
        11.7.2 In-Cell-Art Business Overview
        11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
        11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.7.5 In-Cell-Art Recent Development
    11.8 eTheRNA
        11.8.1 eTheRNA Company Details
        11.8.2 eTheRNA Business Overview
        11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
        11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.8.5 eTheRNA Recent Development
    11.9 Ethris
        11.9.1 Ethris Company Details
        11.9.2 Ethris Business Overview
        11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
        11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.9.5 Ethris Recent Development
    11.10 Tiba Biotechnology
        11.10.1 Tiba Biotechnology Company Details
        11.10.2 Tiba Biotechnology Business Overview
        11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
        11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
        11.10.5 Tiba Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Adeno Carcinomas
    Table 3. Key Players of Mucinous Carcinomas
    Table 4. Key Players of Adenosquamous Carcinomas
    Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2022-2027)
    Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends
    Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers
    Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges
    Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints
    Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2020)
    Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
    Table 22. Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Moderna Therapeutics Company Details
    Table 63. Moderna Therapeutics Business Overview
    Table 64. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
    Table 65. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Moderna Therapeutics Recent Development
    Table 67. CureVac Company Details
    Table 68. CureVac Business Overview
    Table 69. CureVac mRNA Cancer Vaccines and Therapeutics Product
    Table 70. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. CureVac Recent Development
    Table 72. Translate Bio Company Details
    Table 73. Translate Bio Business Overview
    Table 74. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
    Table 75. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Translate Bio Recent Development
    Table 77. BioNTech Company Details
    Table 78. BioNTech Business Overview
    Table 79. BioNTech mRNA Cancer Vaccines and Therapeutics Product
    Table 80. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. BioNTech Recent Development
    Table 82. Sangamo Therapeutics Company Details
    Table 83. Sangamo Therapeutics Business Overview
    Table 84. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
    Table 85. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Sangamo Therapeutics Recent Development
    Table 87. Argos Therapeutics Company Details
    Table 88. Argos Therapeutics Business Overview
    Table 89. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
    Table 90. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Argos Therapeutics Recent Development
    Table 92. In-Cell-Art Company Details
    Table 93. In-Cell-Art Business Overview
    Table 94. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
    Table 95. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. In-Cell-Art Recent Development
    Table 97. eTheRNA Company Details
    Table 98. eTheRNA Business Overview
    Table 99. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. eTheRNA Recent Development
    Table 101. Ethris Company Details
    Table 102. Ethris Business Overview
    Table 103. Ethris mRNA Cancer Vaccines and Therapeutics Product
    Table 104. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Ethris Recent Development
    Table 106. Tiba Biotechnology Company Details
    Table 107. Tiba Biotechnology Business Overview
    Table 108. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
    Table 109. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. Tiba Biotechnology Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Adeno Carcinomas Features
    Figure 3. Mucinous Carcinomas Features
    Figure 4. Adenosquamous Carcinomas Features
    Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Infectious Disease Case Studies
    Figure 7. Cancer Case Studies
    Figure 8. Others Case Studies
    Figure 9. mRNA Cancer Vaccines and Therapeutics Report Years Considered
    Figure 10. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2022-2027)
    Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2020
    Figure 15. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
    Figure 17. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 18. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
    Figure 21. North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
    Figure 22. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
    Figure 23. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
    Figure 27. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
    Figure 28. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
    Figure 29. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2016-2027)
    Figure 39. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
    Figure 47. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
    Figure 48. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
    Figure 49. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
    Figure 55. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 59. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 60. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 61. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 62. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 63. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 64. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 65. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 66. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 67. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Frequently Asked Questions
mRNA Cancer Vaccines and Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
mRNA Cancer Vaccines and Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
mRNA Cancer Vaccines and Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smart Parking System

Smart Parking System market is segmented by company, region (country), by Type, and by Applicatio ... Read More